Stem Holdings inks agreement to acquire 100% of Seven Leaf Ventures
Category: #health  By Pankaj Singh  Date: 2019-12-26
  • share
  • Twitter
  • Facebook
  • LinkedIn

Stem Holdings inks agreement to acquire 100% of Seven Leaf Ventures
  • The new definitive agreement would allow Stem to foray into the lucrative California dispensary market."
     
  • After successful completion of the transaction, Seven Leaf Ventures Chief Executive Officer, Arthur Kwan would be joining Stem Holdings board.

Stem Holdings, Inc., a leading Florida based hemp and cannabis company, has reportedly announced that it has inked a new definitive agreement to procure 100% of private Alberta-based corporation, Seven Leaf Ventures Corp., (7LV) along with its subsidiaries.

The proposed acquisition is being viewed as an arm’s length deal. The Alberta based company has signed a new asset purchase agreement of its own, where it would be acquiring a medical dispensary located in greater Sacramento, California.

The closing of the Sacramento Dispensary acquisition by Seven Leaf is anticipated to take place somewhere in early 2020. The company is also being given the choice to takeover another dispensary located in Los Angeles.

It is expected that the Sacramento Dispensary would drive synergies with the branded premium dispensaries od Stem working in Portland and Eugene, Oregon and Oklahoma City, Oklahoma.

The Florida based cannabis firm also is expecting to receive a recreational license for the Sacramento Dispensary in near term. The projected revenue for the Sacramento Dispensary in 2020 is estimated to be $7.5 million with an EBITDA of over $2.0 million.

Meanwhile, it is being estimated that Seven Leaf would have a working capital of more than C$1.5 million at closing. This working capital would be immediately made available to Stem upon the completion of the transaction.

Under the definitive purchase agreement, Stem Holdings would acquire all outstanding 7LV common shares through a three-cornered amalgamation. Once this transaction is completed, 7LV would become Stem’s wholly-owned subsidiary.

The company would be paying shareholders and average of 13,000,000 shares of Stem’s common stock as a consideration for Seven Leaf shares. 7LV has also given a nod to a contractual lock-up where Stem would be releasing 25% of its shares to 7LV in two business days after Sacramento Dispensary acquisition deal has been closed. The remaining 75% Stem shares would be released 90 days after the closing.

After successful completion of the transaction, Seven Leaf Ventures Chief Executive Officer, Arthur Kwan would be joining Stem Holdings board.

Source credit: https://ir.stemholdings.com/news-events/press-releases/detail/46/stem-holdings-enters-california-dispensary-market-following

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh    

Pankaj Singh

With an experience as an insurance underwriter and a freelance writer under his belt, Pankaj Singh boasts of quite some expertise in the field of content creation. A qualified Post Graduate in Management, Pankaj has also completed a detailed course in Digital Marketin...

Read More

More News By Pankaj Singh

Samsung rolls out its expanded 2021 Odyssey gaming monitor range
Samsung rolls out its expanded 2021 Odyssey gaming monitor range
By Pankaj Singh

Samsung Electronics, one of the leading players in the gaming monitor market, has reportedly announced the commercial launch of its expanded 2021 lineup of Odyssey gaming monitor. Following the launch of its curve-shaped gaming monitor in 2020, the c...

Indonesia to only sell electric motorcycles and vehicles by 2050
Indonesia to only sell electric motorcycles and vehicles by 2050
By Pankaj Singh

The country is seeking to increase the processing of nickel laterite ore which is used in lithium batteries In a bid to reduce carbon emission levels, the Energy Minister of Indonesia, Arifin Tasrif has announced that the nation is planning to only ...

Amway announces Rs 170 crore investment in India over 2-3 years
Amway announces Rs 170 crore investment in India over 2-3 years
By Pankaj Singh

Nutraceuticals giant, Amway, has reportedly made it to the front page following its recent announcement of investing a whopping Rs 170 crore in the Indian sub-continent over the next 2 to 3 years, in an attempt to boost the research and development, ...